Oxcabazepine (®Trileptal) in Anti-Epileptic Polytherapy
The anti-epileptic activity of oxcarbazepine (OXC) was compared with that of carbamazepine (CBZ) and the primary active metabolite of OXC, a monohydroxy derivative (MHD). Altogether 255 patients receiving either OXC or MHD (192 and 63 patients respectively) were included in the analysis of efficacy....
Saved in:
| Main Author: | Peder Klosterskov Jensen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1990-01-01
|
| Series: | Behavioural Neurology |
| Online Access: | http://dx.doi.org/10.3233/BEN-1990-31S106 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Psychiatric comorbidity and quality of life in patients with epilepsy on anti-epileptic monotherapy and polytherapy
by: Jagriti Yadav, et al.
Published: (2022-01-01) -
Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients
by: Sahar Mohamed El-Haggar, et al. -
Acute Generalized Exanthematous Pustulosis (AGEP) Caused by Antibiotic Polytherapy: a Case Report
by: Siniša Jolić, et al.
Published: (2024-01-01) -
Polypharmacy and Polytherapy: Current Perspectives on Risk–Benefit Balance and Strategies for Optimization of Multidrug Treatment in Patients
by: Agata Sozańska, et al.
Published: (2025-06-01) -
EXPERIENCE OF APPLICATION OF SAZAR IN POLYTHERAPY AT SICK OF THE EPILEPSY WITH PARTIAL AND GENERALIZED TONIC-CLONIC CONVULSIVE ATTACKS
by: A. S. Shershever, et al.
Published: (2016-09-01)